Publication | Closed Access

Elevated soluble P-selectin levels are associated with an increased risk of early adverse events in patients with presumed myocardial ischemia

Cardiovascular ToxicityCardiovascular DiseaseEarly Adverse EventsPresumed Myocardial IschemiaVascular BiologyPublic HealthSoluble P-selectin LevelsMedicineCardiologyEpidemiologyAcute Myocardial InfarctionMyocardial Infarction